James Halstead plc (JHD.L) Bundle
Facing a mixed set of signals, James Halstead plc recorded revenue of £262.0m for the year to 30 June 2025, down 4.7% from £274.9m as European and Asia‑Pacific markets softened, yet maintained a robust cash position of £74.3m and minimal debt of £6.4m, underpinning a conservative balance sheet; profitability showed resilience with operating profit rising to £27.1m while profit before tax edged to £55.1m and EPS reached 9.7p, dividends totaled 8.80p for the year, gross margin improved to 44.1% (from 38% the prior year), liquidity metrics remain strong - current ratio 3.34x and cash conversion rate 1.23 - and valuation indicators point to potential upside (market price £135.00 vs. intrinsic estimates of $137.90-$201.52 and a relative fair price of £171.58), even as concentration in the UK (≈75% of revenue in FY2023), raw‑material volatility (PVC), limited online sales (<10%), and trade route disruptions present clear risks alongside growth levers such as international contract wins, R&D in sustainable and antimicrobial flooring, and a planned £400,000 solar investment at Radcliffe that together frame the pivotal data points investors need to examine in detail.
James Halstead plc (JHD.L) - Revenue Analysis
James Halstead plc reported revenue of £262.0m for the fiscal year ending 30 June 2025, a decline of 4.7% from £274.9m in FY24. The drop was driven primarily by weaker performance across European and Asia-Pacific markets, though the company retained a strong cash position.
- FY2025 revenue: £262.0m (down 4.7% vs FY2024)
- FY2024 revenue: £274.9m
- 6 months to 31 Dec 2024: £130.1m (vs £136.5m prior-year period)
- Cash reserves as at 30 June 2025: £74.3m
- Gross margin improvement: 44.1% in FY24 from 38.0% in FY23
- Long-term growth: turnover nearly tripled since 2001
| Period | Revenue (£m) | YoY Change | Gross Margin | Cash Reserves (£m) |
|---|---|---|---|---|
| FY2025 (year to 30 Jun 2025) | 262.0 | -4.7% | - | 74.3 |
| FY2024 (year to 30 Jun 2024) | 274.9 | +- | 44.1% | - |
| FY2023 (year to 30 Jun 2023) | - | - | 38.0% | - |
| 6 months to 31 Dec 2024 | 130.1 | -4.7% vs H1 prior year | - | - |
Key revenue drivers and considerations:
- Regional performance: Europe and Asia-Pacific were the primary sources of the FY2025 decline, reflecting market-specific demand weakness.
- Margin dynamics: The improvement to a 44.1% gross margin in FY24 (from 38.0% in FY23) signals effective cost management and pricing or product-mix benefits despite top-line pressure.
- Liquidity buffer: £74.3m cash provides flexibility to absorb short-term revenue shocks and invest in recovery or growth initiatives.
- Long-term trend: Turnover having nearly tripled since 2001 highlights a history of durable expansion, offering context for the recent cyclical dip.
For more context on ownership and investor interest in the company, see: Exploring James Halstead plc Investor Profile: Who's Buying and Why?
James Halstead plc (JHD.L) - Profitability Metrics
Key profitability figures for the year ending 30 June 2025 show a mixed picture: operating profit rose modestly, while pre-tax and post-tax profits slipped and EPS edged lower. Gross margin trends from prior years demonstrate improving cost control.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Operating profit | £27.1m | £26.2m | - |
| Profit before tax | £55.1m | £56.2m | - |
| Profit after tax | £40.6m | £41.5m | - |
| Earnings per share (EPS) | 9.7p | 10.0p | - |
| Total dividend per share | 8.80p | 8.50p | - |
| Final dividend per share | 6.05p | - | - |
| Gross margin | - | 44.1% (FY24) | 38.0% (FY23) |
- Operating profit increased 3.4% year-on-year (from £26.2m to £27.1m), reflecting tighter operating control.
- Profit before tax declined modestly by £1.1m (1.96%), from £56.2m to £55.1m, indicating non-operating factors or taxation timing impacts.
- Profit after tax fell from £41.5m to £40.6m (down ~2.17%), paralleled by EPS decline from 10.0p to 9.7p.
- Total dividend increased to 8.80p (FY25) from 8.50p (FY24), with a final dividend of 6.05p for FY25 - signalling continued shareholder returns despite slightly lower earnings.
- Gross margin improved materially to 44.1% in FY24 from 38.0% in FY23, highlighting enhanced pricing, mix or cost management ahead of FY25 performance.
Investor implications and focal points for monitoring:
- Track margin sustainability: the jump in gross margin (FY23→FY24) is positive, but confirm whether FY25 maintained those gains in the top line and COGS composition.
- Assess non-operating items driving the small PBT decline despite higher operating profit (foreign exchange, investment income, exceptional items).
- Dividend coverage: with EPS at 9.7p and total dividend 8.80p, payout ratio remains high-monitor free cash flow and balance sheet flexibility.
- Watch management commentary and the updated strategic outlook for FY26 to see if margin improvements can translate into EPS recovery.
For context on corporate direction and long-term priorities, see the company's statement: Mission Statement, Vision, & Core Values (2026) of James Halstead plc.
James Halstead plc (JHD.L) - Debt vs. Equity Structure
James Halstead plc (JHD.L) presents a conservative capital structure as of mid‑2025, characterized by minimal external borrowing, substantial cash reserves and low market volatility sensitivity.- Reported net debt position: very low - gross debt of £6.4m against cash reserves of £74.3m (30 June 2025).
- Market valuation: market capitalisation £629.77m (1 October 2025); enterprise value £572.10m.
- Leverage indicators: low debt-to-equity and debt-to-enterprise-value metrics, supporting financial flexibility.
- Volatility: beta 0.225, indicating substantially lower share price volatility relative to the broader market.
| Metric | Value |
|---|---|
| Gross Debt (30 Jun 2025) | £6.4m |
| Cash Reserves (30 Jun 2025) | £74.3m |
| Net Cash / (Debt) | £67.9m |
| Market Capitalisation (1 Oct 2025) | £629.77m |
| Enterprise Value | £572.10m |
| Beta | 0.225 |
| Cash-to-Debt Ratio | ~11.6x |
| Debt / Market Cap | ~1.02% |
| Debt / Enterprise Value | ~1.12% |
- Liquidity profile: £74.3m in cash provides a strong buffer for working capital needs, capex or opportunistic M&A without heavy reliance on external financing.
- Resilience: negligible debt load reduces interest expense risk and supports dividend sustainability and capital return policies in cyclical downturns.
- Cost of capital implications: low leverage and a beta of 0.225 suggest a lower equity risk premium; management can prioritise shareholder returns or selective reinvestment.
James Halstead plc (JHD.L) - Liquidity and Solvency
James Halstead plc demonstrates robust short-term liquidity and conservative solvency metrics that support both operational flexibility and shareholder returns.
- Current ratio (FY24): 3.34x vs industry median 1.68x - indicates ample short-term coverage of liabilities.
- Quick ratio (excluding inventory): favorable ( >1.0 ), reflecting ability to meet obligations without relying on inventory liquidation.
- Cash conversion rate: 1.23 - efficient conversion of earnings into cash flow.
- Debt-to-equity: low (0.2x) - enhances solvency and reduces financial risk from leverage.
- Cash & equivalents: £74.3 million - a strong cash buffer for reinvestment, acquisitions, dividends, or downturns.
| Metric | FY24 Value | Context / Benchmark |
|---|---|---|
| Current Ratio | 3.34x | Industry median: 1.68x |
| Quick Ratio (ex-inventory) | >1.0 | Indicates liquid asset sufficiency without inventory |
| Cash Conversion Rate | 1.23 | Strong cash generation versus earnings |
| Debt-to-Equity | 0.2x | Low leverage - conservative capital structure |
| Cash & Equivalents | £74.3 million | Available liquidity for growth and contingencies |
- Implication for investors: high current ratio and cash reserves reduce short-term liquidity risk and support capital returns without resorting to high leverage.
- Operational resilience: efficient cash conversion (1.23) means earnings are being converted to cash reliably, which underpins dividend sustainability and the ability to fund expansion.
For further context on shareholder composition and buying patterns, see Exploring James Halstead plc Investor Profile: Who's Buying and Why?
James Halstead plc (JHD.L) - Valuation Analysis
- Intrinsic value range: $137.90 to $201.52 per share (methodology-dependent).
- Current market price: £135.00 per share (suggests moderate undervaluation versus intrinsic estimates).
- Relative (P/E) valuation fair price: £171.58 per share - implied upside 27.1% from current price.
- Market capitalization (as of 1 October 2025): £629.77 million.
- Enterprise value: £572.10 million - reflects a healthy balance between debt and equity.
- Beta: 0.225 - low volatility versus the broader market.
| Metric | Value | Notes |
|---|---|---|
| Intrinsic value (low) | $137.90 | DCF/other conservative methods |
| Intrinsic value (high) | $201.52 | Growth/optimistic assumptions |
| Current market price | £135.00 | Market quote |
| P/E-based fair price | £171.58 | Relative valuation |
| Implied upside (P/E) | 27.1% | From £135.00 to £171.58 |
| Market capitalization | £629.77m | As of 1 Oct 2025 |
| Enterprise value | £572.10m | EV = market cap + debt - cash |
| Beta | 0.225 | Low volatility |
- Valuation context: the divergence between intrinsic estimates (USD) and market price (GBP) underscores the importance of consistent currency adjustments when comparing models.
- Relative valuation uplift (27.1%) highlights potential market mispricing if P/E peers and growth expectations are validated.
- Enterprise value below market cap suggests net cash or modest debt levels supporting financial flexibility.
James Halstead plc (JHD.L) - Risk Factors
James Halstead plc's risk profile centers on raw material exposure, geographic concentration, limited digital channels, logistics volatility and regulatory pressures. Below are the key risk drivers, quantified where possible, and their potential impact.- Raw material cost volatility - PVC and other polymers are primary inputs and have shown sharp price swings over recent years, directly compressing gross margins when costs spike and inventories are re-priced.
- UK revenue concentration - approximately 75% of total revenue for the year ended 30 June 2023 came from the UK, increasing sensitivity to UK construction cycles, public procurement and domestic demand shocks.
- Low digital penetration - online sales account for less than 10% of total sales, leaving the business behind peers that derive a significantly higher share from e-commerce and digital channel efficiencies.
- Logistics and trade-route disruption - past incidents (e.g., Red Sea tensions) raised freight costs and caused delivery delays, increasing landed cost and reducing availability in export markets.
- Regulatory and compliance risk - tightening environmental and workplace safety standards in both the UK and export markets could require capital expenditure, process changes and higher operating costs.
| Risk | Relevant FY2023 Metric / Fact | Potential Impact |
|---|---|---|
| Raw material cost swings (PVC) | Significant historical volatility in polymer inputs; company notes cost pressure periods | Gross margin compression; potential short-term operating profit reduction |
| Geographic concentration | ~75% revenue from UK (year ended 30 June 2023) | High revenue exposure to UK market downturns; limited diversification |
| Digital sales penetration | Online sales <10% of total | Missed growth and margin opportunities vs digital-first peers; slower customer acquisition |
| Freight & trade-route disruption | Documented past increases in freight costs tied to global route disruptions | Higher COGS for exports; delivery delays; margin erosion in international sales |
| Regulatory/environmental | Exposure across multiple jurisdictions with differing standards | CapEx and compliance cost increases; potential restrictions in some markets |
- Inventory and procurement strategy: fluctuating input prices create trade-offs between holding larger inventories (hedging price risk) and increased working capital costs; inconsistent raw material pricing can cause margin volatility quarter-to-quarter.
- Market diversification constraints: reliance on the UK (75%) limits scale benefits from faster-growing international markets and increases sensitivity to UK public sector demand patterns.
- Channel strategy weakness: with online sales <10%, scaling digitally could improve margins and reach; failure to invest meaningfully here risks ceding share to digitally native competitors.
- Logistics exposure: concentrated shipping lanes and reliance on global freight capacity mean geopolitical events (e.g., Red Sea disruptions) can materially raise freight costs and delay shipments.
- Compliance costs: evolving environmental and workplace safety rules may force manufacturing process upgrades or product reformulations, increasing near-term capital outlay and unit costs.
James Halstead plc (JHD.L) - Growth Opportunities
James Halstead plc (JHD.L) shows several clear vectors for top-line expansion and margin improvement driven by geographic wins, product innovation, capital investment and sustainability initiatives.- Geographic expansion: recent significant business secured in the UAE, Colombia, Iceland, Italy, Mexico, Poland, Greece and South Africa signals diversification beyond core UK and European markets and reduces single-market exposure.
- Product-led growth: focused R&D into slip-resistant, antimicrobial and sustainable flooring broadens addressable markets (healthcare, education, hospitality) and supports higher-margin specification sales.
- Operational leverage: completed capex across Teesside and Radcliffe upgrades improves throughput and supports incremental revenue without proportional increases in fixed costs.
- Sustainability investment: preparatory work for a £400,000 solar panel installation at Radcliffe reduces energy cost volatility and improves ESG credentials versus peers.
| Growth Driver | Concrete Evidence / Metric | Implication for Investors |
|---|---|---|
| Geographic wins | Signed material business in UAE, Colombia, Iceland, Italy, Mexico, Poland, Greece, South Africa | Revenue diversification; upside from emerging market penetration |
| Product innovation | R&D programs targeting slip-resistant, antimicrobial, sustainable ranges | Higher specification sales, pricing power, repeat institutional contracts |
| Capex | Completion of production upgrades at Teesside and Radcliffe | Increased capacity and efficiency; lower unit costs |
| Energy sustainability | £400,000 planned solar panel investment at Radcliffe | Lower energy cost base; stronger ESG reporting |
| Historical revenue growth | Turnover nearly tripled since 2001 (implies mid-single-digit CAGR over two decades) | Proven long-term growth track record supporting conservative continuity of growth |
- R&D cadence and product pipeline: continued reinvestment into new formulations and manufacturing techniques positions James Halstead to win specification-led contracts (hospitals, schools, public sector) where antimicrobial and slip-resistant credentials are prioritized.
- Margin expansion potential: operational improvements from recent capex and energy savings from solar investment can contribute to EBITDA conversion if sales grow in tandem.
- Scalability risks and mitigants: international contract execution depends on logistics, local standards and distributor relationships - the company's recent wins across diverse jurisdictions show operational capability but will require sustained commercial support.

James Halstead plc (JHD.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.